Unapproved drops for dry eyes pose risks: Govt
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Govt highlights multi-layer framework to curb misleading advertisements
Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal
Study finds rising resistance to a last-resort antibiotic in Africa
Patna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
Pharma Company Bus Overturns in Miyapur, 10 Employees Injured, Probe Underway
India regulator asks states to implement uniform drug licensing norms to end quality gaps
Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concernFake MBBS degree provider Doctor has been arrested by Mumbai Police
Several specialist doctors were found guilty to have procured fake postgraduate degrees from the College of Physicians and Surgeons (CPS). With this regard, the first arrest has been made by…
Nationwide Census has been launched by the Indian Government To Create India’s First NHRR
Countrywide census project has been launched to develop the NHRR (National Health Resource Repository) by the Union Health Ministry. NHRR will be India’s first registry of authentic and updated geospatial…
Children are not safe from Diabetes, either
New Delhi: Even Children may become diabetic. It may seem odd on the face of it but the reality is far more frightening. Even newborns are being found packed with…
Nifty Pharma index rises; Lupin, Cipla shares shine
NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday. Shares of Lupin (up 1.64 per…
Bayer profit flat as weak animal health offsets strong Xarelto
By Ludwig Burger FRANKFURT: Bayer’s adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and…
Cipla’s subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
Drug major Cipla Tuesday said its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around…
Aurobindo Pharma shares fall 3% after Q2 earnings
New Delhi: Shares of Aurobindo Pharma Tuesday fell almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit for the quarter ended September 30,…
Medikabazar goes for leadership boost
New Delhi: Medikabazar, India’s leading B2B online aggregator for medical supplies is in the cusp of massive growth. Hence, it has gone for leadership augmentation. Medikabazaar recently announced the appointment…
Lupin launches generic pneumonia drug in US
New Delhi: Drug firm Lupin said Monday it has launched the generic Atovaquone oral suspension, which is used for the prevention and treatment of pneumonia, in the US market. The…
Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients
Drug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral eye infection in AIDS patients. Valganciclovir…